Swiss Life PPLI Review: Issuers, Ratings and Merger
Swiss Life offers international insurance-based wealth planning through distinct legal insurers. For a proposal, identify the Luxembourg or Singapore company, or Elips Life AG following the 2026 Liechtenstein merger. Then check that entity's financial evidence, policy terms and permitted market. The published A+ rating belongs to Swiss Life Ltd in Switzerland, not automatically to every subsidiary. We also look at the 2021 U.S. deferred prosecution agreement. If you are a U.S. person, get written confirmation of eligibility and tax qualification for the specific contract.
Rating check. Match the rating to its named legal entity. A shared brand does not give a subsidiary the parent's rating, and parent support only counts if there is an enforceable guarantee.
Current focus. The Liechtenstein merger has been announced as completed. Reconcile your policyholder notice, successor insurer and any termination rights.
Research context: part of our PPLI provider comparison.
An insurance wrapper combines an insurance contract with underlying investments. At Swiss Life, the useful comparison is between named insurers and contracts. Below we take company marketing, financial reports, legal protections and enforcement records in turn. Source check: 17 September 2026.
Which entity actually issues the policy
The business is marketed as Global Private Wealth within Swiss Life Global Solutions. The company does use PPLI terminology in some material: its Spanish unit-linked planning article describes Life Asset Portfolio as a private placement life insurance product. Whatever the product is called, U.S. tax treatment depends on whether the contract meets U.S. rules.
- Swiss Life (Luxembourg) S.A.: Luxembourg insurer established in 1985, identified in the company history and CAA insurer register. Its financial report covers both Private Wealth and Employee Benefits.
- Elips Life AG: Liechtenstein successor following the absorption of Swiss Life (Liechtenstein) AG. The August 2026 completion announcement confirms that the merger occurred.
- Swiss Life (Singapore) Pte. Ltd.: the MAS register identifies it as a Direct Insurer (Life). Its product range and contract terms require separate review.
- Swiss Life Ltd, also Swiss Life AG: the Switzerland-based insurer named in the group's A+ financial-strength rating disclosure. Rely on its rating only where it is the company actually issuing your policy.
Similar name, separate entity: the CAA register also lists Swiss Life Products (Luxembourg) S.A. Do not attach Swiss Life (Luxembourg) S.A.'s financial report to a policy issued by that other company. Match the complete legal name and identification number.
Named offerings include country-specific Life Asset Portfolio contracts and Swiss Life Generations. The Asian product page lists Alpha, Alpha Plus, Gemstone, Zenith and Infinity, among other products. Match the precise product version, issuing insurer, residence and ownership structure. Products sold under the same brand can differ in benefits and tax treatment.
The rating question, stated precisely
The Swiss Life investor disclosure records S&P Global Ratings' confirmation on 12 August 2026. It distinguishes the Switzerland-based operating insurer from the holding company:
| Named entity | Rating type | Rating and outlook |
|---|---|---|
| Swiss Life Ltd, Switzerland | Insurer financial strength | A+, Stable |
| Swiss Life Holding Ltd | Issuer credit | A-, Stable |
Swiss Life Ltd's rating tells you about Swiss Life Ltd. It does not carry over to the Luxembourg, Liechtenstein or Singapore issuer. If a proposal claims an entity-specific rating, obtain the agency record. If it relies on parent support, obtain the signed guarantee and check the beneficiary, covered obligations, limits, duration and enforceability.
We are not saying the other subsidiaries are unrated; a group webpage simply cannot tell you whether an agency has rated an affiliate. Also note that the merger Q&A labels the holding company's A- rating as financial strength; the dedicated ratings disclosure identifies it as an issuer-credit rating. Use the precise rating type in a comparison.
Identify the policy, jurisdiction and decision you need to examine. Use the consultation form to describe the issue and the professional support you are seeking.
Describe your question →Financial scale
Swiss Life's 24 April 2026 announcement reports a group Swiss Solvency Test (SST) ratio of 213% at 31 December 2025. The 1 September 2026 half-year release gives an estimated ratio of around 215% at 30 June 2026. These are Swiss group measures. They are not the Luxembourg insurer's Solvency II ratio, and they say nothing about the value of your investments.
The Swiss Life (Luxembourg) 2025 SFCR provides issuer-specific figures at 31 December 2025. Its Solvency II balance sheet and capital table support the following comparison. Amounts are rounded from figures reported in thousands of euros.
| Measure | Reported amount | Scope |
|---|---|---|
| Total assets | EUR16.127 billion | Solvency II valuation |
| Index-linked and unit-linked assets | EUR14.001 billion | Assets backing linked contracts |
| Eligible own funds for SCR | EUR377.965 million | Capital eligible for the SCR comparison |
| Solvency Capital Requirement | EUR192.594 million | Issuer capital requirement |
| SCR coverage | 196% | 2024 comparison: 161% |
The Swiss Life (Liechtenstein) 2025 SFCR reports CHF40.9 million of eligible own funds to meet the Solvency Capital Requirement and CHF25.0 million of SCR. These are the predecessor's figures from before the 2026 merger, not Elips Life AG's position afterwards. For an ongoing policy, obtain the successor's relevant accounts and capital information.
SST and Solvency II use different methods and cover different perimeters, so a lower percentage under one regime does not make an insurer weaker than one measured under the other. Compare like with like: for each issuer, look at eligible capital, capital requirements, exposures and how they have moved over time. And keep the two balance-sheet items apart: assets backing policyholders' investments are not capital available to absorb the insurer's own losses.
The 2026 Liechtenstein merger: identify the current issuer
Elips Life's August 2026 announcement confirms completion of the absorption merger. Swiss Life's Global Private Wealth Q&A gives 30 June 2026 as the transfer date for all Swiss Life (Liechtenstein) AG insurance contracts and says policy terms and benefits continue under Elips Life AG. The Q&A therefore covers Private Wealth customers, not only employee-benefit business.
The French official notice published on 9 July 2026 records regulatory approval on 24 June and an effective date of 29 June for the French portfolio. It identifies Elips Life AG with LEI 391200QF68RDVVTQHJ76. Keep that French date for French policies rather than replacing it with the 30 June date in the carrier Q&A. For an existing policy, reconcile the notices and the insurer shown on current statements.
The termination periods differ. The carrier Q&A describes an extraordinary right exercisable within three months of receiving the letter. The French notice grants affected French policyholders one month from its publication under Insurance Code Articles L.324-1 and L.364-1. By the date of this review, either window may already have closed. Have the applicable notice, receipt date and local rules checked before acting.
- Match the former issuer, policy number and successor shown in your notices.
- Obtain the current servicing contact, payment instructions and claims procedure through verified insurer channels.
- Ask for applicable post-merger financial information and confirmation of contractual guarantees.
- Record the relevant notice date and obtain advice on any termination or other rights.
Policyholder protection
Swiss Life's April 2025 Triangle of Security explainer describes the insurer, custodian bank and Commissariat aux Assurances. For the actual mechanism, the CAA deposit-agreement model provides for inventoried assets backing technical provisions, segregation and preferential insurance claims. The model is an insurer-bank agreement subject to CAA oversight, including the specified approval and freezing powers.
A preferential claim over a defined pool of assets puts you at the front of the queue. It is not a compensation scheme, and it does not promise full or immediate recovery. The CAA model distinguishes securities from cash deposits in a bank insolvency. Market losses on non-guaranteed policy investments remain possible, while any insured benefit depends on the contract and insurer. Our Luxembourg Triangle of Security analysis explains these limits.
Liechtenstein's government English translation of the Insurance Supervision Act describes a separate estate for assets covering technical provisions in Article 161, insurance-claim priority in Article 161a and the special register in Article 162. The translation reflects the stated 1 February 2025 version; current controlling law and the contract must be checked. Like the Luxembourg model, it gives priority, not a guarantee of investment performance, full recovery or immediate access during an insolvency.
Investment flexibility, minimums and costs
Investment permissions depend on the contract and jurisdiction. The Swiss Life Generations brochure, version 03.22 describes a discretionary mandate, with the proposed custodian and asset manager subject to insurer approval. It lists external funds, Luxembourg dedicated and internal collective funds, and a Liechtenstein investment portfolio. Treat that list as a guide to what the product can accommodate, then confirm that your specific assets, manager or self-managed arrangement are acceptable today.
Luxembourg's CAA Circular Letter 26/1 sets investment conditions and client categories. The insurer's own product minimums and investment approval sit on top of those regulatory permissions, and for a U.S. person the investor-control rules apply as well. Revenue Ruling 2003-91 evaluates actual control under specified facts, including restrictions on directing particular investments and related communications.
Some historical product thresholds are public. The Generations brochure marked 03.22 states a EUR1 million initial premium, EUR50,000 minimum additional contribution and EUR1.5 million minimum sum assured, with currency equivalents possible. The maximum sum assured shown is EUR65.5 million. They come from a dated brochure, so treat them as a guide to scale, not as a current quote, a group-wide minimum or a sign of U.S. availability. Obtain written terms for the named issuer, product version and market.
Compare the current Key Information Document, full policy wording, charge schedule and personalised illustration. Include entry charges, administration, cost of insurance, fund and manager fees, custody, transactions, currency conversion, surrender and loan costs. Maximum charges in 2018 documents are a historical reference; your terms will be whatever is negotiated now. Use the PPLI costs and economics guide to align premium dates, insured assumptions, investment returns and exit dates across proposals.
Regulatory record: the 2021 US deferred prosecution agreement
On 14 May 2021, the U.S. Department of Justice announced a deferred prosecution agreement involving Swiss Life Holding AG, Swiss Life (Liechtenstein) AG, Swiss Life (Singapore) Pte. Ltd. and Swiss Life (Luxembourg) S.A. The executed agreement and statement of facts document the admitted conduct and obligations.
The admitted conduct concerned U.S. taxpayers, approximately 1,608 insurance-wrapper policies and more than $1.452 billion in offshore assets during 2005 to 2014. Swiss Life Holding agreed to pay $77,374,337, comprising $16,345,454 restitution, $35,782,375 forfeiture of gross fees and $25,246,508 penalties. So the total was not a single fine: restitution, forfeiture and penalties are different things.
The agreement provided a three-year deferral, with dismissal to be sought if its conditions were met. A deferred prosecution agreement is not a conviction. Equally, the passage of three years does not by itself mean a dismissal order was entered, and the records we reviewed do not show the current docket status. DOJ also credited cooperation, client outreach and remedial measures, and required continued cooperation and disclosures, including under the Swiss Bank Program.
The history matters for any U.S.-connected wrapper because it concerns exactly that business and client group. It is a record of past conduct; it tells you nothing about current conduct or today's acceptance rules. Request the issuer's written U.S.-connection policy, required declarations, reporting process and escalation procedure for changes in residence or ownership.
This review is not a clean regulatory or litigation certificate. Search the records for the actual entity and former names, including the relevant FINMA, CAA, Liechtenstein FMA or MAS record. Distinguish allegations, findings, settlements and dismissed proceedings. A public search of this kind cannot rule out other enforcement or material litigation.
US taxpayers
Current U.S. acceptance and policy tax qualification are separate questions. Obtain written confirmation for the issuer, product, policyholder, beneficial owner and insured. IRC § 7702 supplies federal life-insurance qualification rules; variable-contract diversification and investor control require separate analysis. A § 953(d) election concerns a foreign insurer's treatment as a domestic corporation for U.S. tax purposes. The election on its own says nothing about whether a particular policy complies.
Historical public forms do address U.S. connections. A Liechtenstein self-declaration form marked 16-07-15 includes both U.S.-person and non-U.S.-person choices and requests reporting documents for U.S. persons. That shows a process existed at the time; it does not show that new U.S. business is accepted today. Equally, the absence of a U.S. marketing page or of a listing in a Senate provider list does not mean the business is prohibited. Obtain the current acceptance decision and tax analysis.
Frequently Asked Questions
Is Swiss Life rated A+?
The group's investor page records an A+ financial-strength rating with stable outlook for Swiss Life Ltd in Switzerland, confirmed on 12 August 2026. It separately records Swiss Life Holding Ltd at A-, Stable, for issuer credit. Neither rating carries over automatically to a Luxembourg, Liechtenstein or Singapore policy issuer.
Does Swiss Life offer PPLI to US taxpayers?
The public record does not answer that for today. Historical U.S.-person forms and the 2021 agreement show that U.S. clients were part of the business in the past, but current acceptance and U.S. tax qualification need a written answer for the exact issuer, product, owner, beneficial owner and insured.
What is the minimum premium?
The Swiss Life Generations brochure marked 03.22 shows a EUR1 million initial premium, but that figure is historical and specific to one product. It is not a current group-wide minimum or a U.S. quotation. Confirm the current initial premium, further contributions and death benefit separately.
What is happening in Liechtenstein?
Elips Life announced completion of the merger in August 2026. Its Global Private Wealth Q&A gives 30 June as the transfer date; the French official notice gives 29 June for the relevant portfolio. Match your policyholder notice, current insurer and applicable termination rights.
Research updated 17 September 2026 using the linked issuer disclosures, financial reports, regulatory records and legal sources. Before engaging a participant, obtain written confirmation of its role and any fee, commission or referral payment. See our editorial standards. This is general research, not individual legal, tax or insurance advice. Submit a PPLI inquiry.
Correction history: the 15 September 2026 revision updated transfer evidence and separated group ratings from issuer financials. On 17 September, this review corrected the blanket unrated-subsidiary and PPLI-terminology claims, added the completed-merger announcement and issuer solvency figures, distinguished termination notices, and dated the historical product thresholds and U.S.-person form.
Eldar leads PPLI.com’s strategy, research and partnerships. He acquired PPLI.com in 2020 and has worked on private placement life insurance since then.
Use the consultation form to describe your question and the support you are seeking. Review the Privacy Policy before sharing personal information.
Prefer to begin with a single question? Write to info@ppli.com